DnB Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Buy
+3,952
New +$241K ﹤0.01% 1091

Other funds holding TVTX

DnB Asset Management's TVTX Position: Q3 2026 in Review

DnB Asset Management opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 3,952 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1091 among its holdings.

345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • DnB Asset Management held 3,952 shares of Travere Therapeutics worth $233K as of Q3 2026.
  • Travere Therapeutics was a new DnB Asset Management position in Q3 2026.
  • Travere Therapeutics made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #1091 holding.
  • 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.